Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency Department Visits After Radiotherapy in Patients with Solid Malignancies: Analysis of Causality and Severity.

Oncology·2026
Same author

Qualitative Analysis of Discrepancy Patterns Between Large Language Models and Human Reviewers in Abstract Screening for Systematic Reviews.

Journal of epidemiology·2026
Same author

Postmastectomy radiation therapy for patients with pT1-2N1 breast cancer over 2 decades in Korea: Korean Radiation Oncology Group 14-21.

Radiation oncology journal·2026
Same author

Effectiveness of Radiotherapy for Hepatocellular Carcinoma with Lymph Node Metastasis: A Meta-Analysis.

Cancer research and treatment·2025
Same author

Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics.

PloS one·2025
Same author

Clinical Significance of Biliary Invasion at Diagnosis in Barcelona Clinic Liver Cancer Stage B-C Hepatocellular Carcinoma: A Nationwide Cohort Analysis in South Korea.

Oncology·2024

Related Experiment Video

Updated: Jun 3, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

Systematic Review-Based Treatment Algorithm for the Multidisciplinary Treatment of Lung Cancer Bone Metastases.

Ah Reum Lim1, Won Sup Yoon2, Sunmin Park2

  • 1Department of Internal Medicine, Division of Oncology, Korea University Ansan Hospital, Korea University, Ansan-si 15355, Republic of Korea.

Cancers
|January 8, 2025
PubMed
Summary

Novel systemic agents improve lung cancer bone metastases prognosis. A new algorithm guides multidisciplinary decisions by analyzing factors like EGFR status and ECOG performance, aiding patient management.

Keywords:
NSCLCbone metastaseslung cancertreatment algorithm

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.0K

Related Experiment Videos

Last Updated: Jun 3, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.0K

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Prognosis for lung cancer with bone metastases has improved due to novel systemic agents.
  • Patients often require surgery or radiotherapy for symptom management.
  • A disease-specific algorithm is lacking for multidisciplinary decision-making.

Purpose of the Study:

  • To develop a treatment algorithm for managing non-small cell lung cancer (NSCLC) bone metastases.
  • To identify and quantify prognostic factors influencing survival in these patients.

Main Methods:

  • Systematic review of studies published after 2000, including those with ≥10 patients and multivariate survival analysis.
  • Categorization of clinical factors and calculation of pooled hazard ratios (HRs).
  • Development of a treatment algorithm based on clinical importance and pooled HRs.

Main Results:

  • Fifteen studies with 3759 patients were analyzed; median survival ranged from 1.8-28.3 months.
  • Epidermal Growth Factor Receptor (EGFR) status (HR: 2.109) and ECOG performance (HR: 2.007) were significant prognostic factors.
  • Other key factors included visceral metastases, bone metastasis characteristics, systemic treatment, and smoking status.

Conclusions:

  • Multiple interrelated factors significantly influence oncological prognoses in lung cancer bone metastases.
  • The proposed treatment algorithm supports multidisciplinary management strategies for NSCLC bone metastases.